Addendum
Tafluprost/timolol (Addendum to Commission A14-49)
Report documents
-
Addendum
Tafluprost/timolol (Addendum to Commission A14-49)
Additional information
Project details
- Project no.
- A15-19
- Commission
- Commission awarded on 26.05.2015 by the Federal Joint Committee (GBA).
- Report type
- Addendum
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Head and nerves
- Note
-
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
Connected Projects
-
Dossier assessment
Tafluprost/timolol - Benefit assessment according to §35a Social Code Book V (dossier assessment)
Status: Commission completed